Immunogenicity 451
Sample ID
None
Response
Negative
Tumor Type
Melanoma
Gene Symbol
OVGP1
Transcript ID
None
HLA INFO
A*66:01
TCR INFO
No TCR info found!
Full length protein sequence (678 aa)
MWKLL
1
LWVGL
6
VLVLK
11
HHDGA
16
AHKLV
21
CYFTN
26
WAHSR
31
PGPAS
36
ILPHD
41
LDPFL
46
CTHLI
51
FAFAS
56
MNNNQ
61
IVAKD
66
LQDEK
71
ILYPE
76
FNKLK
81
ERNRE
86
LKTLL
91
SIGGW
96
NFGTS
101
RFTTM
106
LSTFA
111
NREKF
116
IASVI
121
SLLRT
126
HDFDG
131
LDLFF
136
LYPGL
141
RGSPM
146
HDRWT
151
FLFLI
156
EELLF
161
AFRKE
166
ALLTM
171
RPRLL
176
LSAAV
181
SGVPH
186
IVQTS
191
YDVRF
196
LGRLL
201
DFINV
206
LSYDL
211
HGSWE
216
RFTGH
221
NSPLF
226
SLPED
231
PKSSA
236
YAMNY
241
WRKLG
246
APSEK
251
LIMGI
256
PTYGR
261
TFRLL
266
KASKN
271
GLQAR
276
AIGPA
281
SPGKY
286
TKQEG
291
FLAYF
296
EICSF
301
VWGAK
306
KHWID
311
YQYVP
316
YANKG
321
KEWVG
326
YDNAI
331
SFSYK
336
AWFIR
341
REHFG
346
GAMVW
351
TLDMD
356
DVRGT
361
FCGTG
366
PFPLV
371
YVLND
376
ILVRA
381
EFSST
386
SLPQF
391
WLSSA
396
VNSSS
401
TDPER
406
LAVTT
411
AWTTD
416
SKILP
421
PGGEA
426
GVTEI
431
HGKCE
436
NMTIT
441
PRGTT
446
VTPTK
451
ETVSL
456
GKHTV
461
ALGEK
466
TEITG
471
AMTMT
476
SVGHQ
481
SMTPG
486
EKALT
491
PVGHQ
496
SVTTG
501
QKTLT
506
SVGYQ
511
SVTPG
516
EKTLT
521
PVGHQ
526
SVTPV
531
SHQSV
536
SPGGT
541
TMTPV
546
HFQTE
551
TLRQN
556
TVAPR
561
RKAVA
566
REKVT
571
VPSRN
576
ISVTP
581
EGQTM
586
PLRGE
591
NLTSE
596
VGTHP
601
RMGNL
606
GLQME
611
AENRM
616
MLSSS
621
PVIQL
626
PEQTP
631
LAFDN
636
RFVPI
641
YGNHS
646
SVNSV
651
TPQTS
656
PLSLK
661
KEIPE
666
NSAVD
671
EEA
676
Mutation Information
DNA mutation:
None
Peptide Range:
442 ~ 469
Mut AA position:
446 (5 in Wild Type peptide)
Alignment
Wild Type:
"--------MTITPRGTTV----------
||||.|||||
Mutant:
EIHGKCENMTITSRGTTVTPTKETVSLG"
Nature, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaGene Name (from Reference) OVGP1
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
peptide
T-cell
Source
PBMCs
APC
Type
autologous APCs
Assay
IFNg ELISPOT assay